BB Biotech as of Sept. 30, 2012
Portfolio Holdings for BB Biotech
BB Biotech holds 19 positions in its portfolio as reported in the September 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 18.2 | $208M | 2.7M | 76.40 | |
| Gilead Sciences (GILD) | 12.2 | $140M | 2.1M | 66.33 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 11.4 | $130M | 2.3M | 55.89 | |
| ISIS Pharmaceuticals | 9.2 | $105M | 7.5M | 14.07 | |
| Incyte Corporation (INCY) | 7.6 | $87M | 4.8M | 18.05 | |
| Ariad Pharmaceuticals | 5.6 | $64M | 2.6M | 24.21 | |
| ImmunoGen | 4.5 | $52M | 3.6M | 14.59 | |
| Alexion Pharmaceuticals | 4.5 | $52M | 450k | 114.40 | |
| Medivation | 4.1 | $47M | 825k | 56.35 | |
| Onyx Pharmaceuticals | 4.0 | $46M | 547k | 84.50 | |
| Halozyme Therapeutics (HALO) | 3.6 | $42M | 5.5M | 7.54 | |
| Medicines Company | 3.6 | $41M | 1.6M | 25.81 | |
| BioMarin Pharmaceutical (BMRN) | 3.4 | $39M | 976k | 40.26 | |
| Theravance | 1.9 | $22M | 843k | 25.91 | |
| Optimer Pharmaceuticals | 1.8 | $20M | 1.4M | 14.12 | |
| Endocyte | 1.7 | $19M | 2.0M | 9.97 | |
| Achillion Pharmaceuticals | 1.5 | $18M | 1.7M | 10.41 | |
| Dendreon Corporation | 0.6 | $7.3M | 1.5M | 4.81 | |
| Idenix Pharmaceuticals | 0.5 | $5.7M | 1.3M | 4.56 |
